Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Tuesday, March 10, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for March 2, 2014 through March 6, 2014

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Administration for Children and Families (ACF)

·         Centers for Disease Control and Prevention (CDC)

·         Health Resources and Services Administration (HRSA)

·         Office of the Assistant Secretary for Health (OASH)

·         Substance Abuse and Mental Health Services Administration (SAMHSA)

·         US Army Medical Research Acquisition Activity (USAMRAA)

·         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

ACF: Personal Responsibility Education Program (PREP)

Funding Opportunity Number: HHS-2015-ACF-ACYF-AK-0984

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the development and implementation of the Personal Responsibility Education Program (PREP) in Florida, Indiana, North Dakota, Texas, Virginia, Guam, American Samoa, the Northern Mariana Islands, the Marshall Islands and Palau. The purpose of this program is to support projects that educate youth, between the ages of 10 and 19 years, and pregnant and parenting youth under age 21, on abstinence and contraception for the prevention of pregnancy, sexually transmitted infections, and HIV/AIDS. Projects are also required to implement at least three of six adulthood preparation subjects. This funding opportunity was announced on March 6, 2015. The application deadline is May 5, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACF: Refugee Individual Development Accounts (IDA) Program

Funding Opportunity Number: HHS-2015-ACF-ORR-ZI-0958

This Funding Opportunity Announcement (FOA) invites eligible entities to submit competitive grant applications for projects to establish and manage Individual Development Accounts (IDAs) for low-income refugee participants. Eligible refugee participants who enroll in these projects will open and contribute systematically to IDAs for specified savings goals, including home ownership, business capitalization, vehicles for educational or work purposes, professional certification, and education (limited to postsecondary education, college entrance exam fees, Test of English as a Foreign Language (TOEFL) and GED preparation and test fees). Grantee organizations may use ORR funds to provide matches for the savings in the IDAs of up to $2,000 per individual refugee and $4,000 per refugee household. Successful grantees will be expected to coordinate their policies and procedures for developing and administering refugee IDA projects with ORR and with the existing refugee IDA network. This funding opportunity was announced on March 4, 2015. The application deadline is May 4, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

CDC: National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome

Funding Opportunity Number: CDC-RFA-DD15-1505

The purpose of this Funding Opportunity Announcement (FOA) for the National Public Health Practice and Resource Centers (NPHPRC) on Health for Children with Attention-Deficit/Hyperactivity Disorder (ADHD) or Tourette syndrome (TS) is to fund centers that have the capacity to develop and provide health promotion programs and health communication and education resources for both professionals and the public regarding ADHD or TS. The NPHPRC’s mission is to provide information, education and consultation about assessment, diagnosis, treatment, and health and well-being for children with ADHD or TS. Program strategies should include (1) information, consultation and referral, (2) health communication programs and materials development, and (3) education and training. Other target audiences in the NPHPRC’s health promotion mission are health care professionals, education professionals, caregivers, and the public. Health promotion for children with ADHD or TS requires condition-specific information in addition to information and activities that address common aspects of living with ADHD or TS. The intended long-term outcomes of the program are to promote optimal health and well-being of children with ADHD or TS. Increased access to and awareness of available support services and treatments for ADHD or TS among the community, public, healthcare, and educational professionals; increased knowledge among individuals about ADHD or TS receiving information or educational materials from the NPHPRC; increased knowledge among individuals attending education programs on ADHD or TS; increased intention to act on information presented by adopting health behaviors, treatment or educational strategies presented among people attending education programs, receiving educational materials, or other program contents. This funding opportunity was announced on March 6, 2015. The application deadline is May 11, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

CDC: Promoting Access to Guidelines-Based Care for People with Asthma

Funding Opportunity Number: CDC-RFA-EH15-1503

The purpose of this Funding Opportunity Announcement (FOA) is to promote access to guidelines-based asthma care using health education and communication strategies that will result in measurable impacts. These efforts will be supported by core public health activities such as partnership engagement, workforce development, guidance and support for programmatic efforts, strategic communication, and evaluation. These infrastructure activities will support communication and education interventions tailored to multiple audiences, including people with asthma and their caregivers, school personnel, and health care providers. Awardees will provide clear, consistent, and straightforward guidance on the delivery of asthma education for people with asthma, health professionals, and to the interactions between these two groups. As a result of these interventions, audiences will have the knowledge and skills to demand appropriate care (people with asthma) or deliver it (health care providers), and schools and communities will have the capacity to promote policies, systems, and environments that support people with asthma. This funding opportunity was announced on March 6, 2015. The application deadline is May 5, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

CDC: Maternal and Child Health Epidemiology: National and State Coalition Capacity Building to Improve Outcomes

Funding Opportunity Number: CDC-RFA-DP15-1507

The purpose of this Funding Opportunity Announcement (FOA) is to increase the capacity of the maternal and child health (MCH) professional workforce to analyze and use data, and to apply evidence-based approaches to MCH program and policy development at local, state, and national levels. The goal of this FOA is to develop strategies such as training, peer exchange, dissemination of guidelines and programmatic recommendations. These strategies are expected to result in increased use of evidence-based MCH programs at local, state, and national levels by MCH professionals. Achievable results may include (1) a knowledgeable, capable, and well-trained workforce; (2) improved collaboration and engagement with clinicians; and (3) broader dissemination of research findings. The long-term expected outcome is a change in maternal behavior that impacts birth, infant, and childhood outcomes and ultimately improves the health of women, infants, and families. This funding opportunity was announced on March 6, 2015. The application deadline is May 18, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

CDC: Working with Publicly Funded Health Centers to Reduce Teen Pregnancy among Youth from Vulnerable Populations

Funding Opportunity Number: CDC-RFA-DP15-1508

The purpose of this Funding Opportunity Announcement (FOA) is to implement a new five-year initiative to (1) enhance publicly funded health centers' capacity to provide youth-friendly sexual and reproductive health services, and (2) increase the number of youth accessing sexual and reproductive health services by (a) working with youth-serving systems to develop strategies to refer and link vulnerable youth to care and (b) increasing awareness of the health centers and other services in the local community through communication efforts. This funding opportunity was announced on March 6, 2015. The application deadline is May 15, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

HRSA: Health Infrastructure Investment Program

Funding Opportunity Number: HRSA-15-129

This Funding Opportunity Announcement (FOA) solicits applications for the Health Infrastructure Investment Program (HIIP) for existing Health Center Program grantees to increase their patient capacity and to provide additional comprehensive primary and preventive health services to medically underserved populations through the alteration/renovation, expansion, or construction of a facility. HIIP funding will support one capital project at a new or existing site within the applicant’s approved scope of project for alteration/renovation (A/R) or construction/expansion (C/E) projects. A/R projects can include work required to modernize, improve, and/or reconfigure the interior arrangements of an existing facility; work to improve and/or replace exterior envelope; work to improve accessibility (such as sidewalks and ramps), and/or life safety requirements in an existing facility.  This type of project would not increase the total square footage of an existing building and does not require ground disturbance or footings.  This type of project may include the purchase of related moveable equipment. C/E projects can include the construction of a new stand-alone structure and/or associated work required to expand a structure to increase the total square feet of a facility. Construction projects may include the installation of a permanently affixed modular or prefabricated building and/or the purchase of related moveable equipment. Eligible health center applicants may submit only one HIIP application proposing one site-specific, stand-alone facility project.  HIIP applicants must demonstrate how the A/R, and/or C/E project will improve their capacity to provide comprehensive primary and preventive health services to medically underserved populations. This funding opportunity was announced on March 3, 2015. The application deadline is April 21, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

OASH: College Sexual Assault Policy and Prevention Initiative

Funding Opportunity Number: WH-AST-15-002

The Office on Women's Health (OWH) provides national leadership and coordination to improve the health of women and girls through policy, education, and model programs. OWH works with numerous government agencies, non-profit organizations, consumer groups, and associations of health care professionals to advance this mission. OWH has a history of working to stop violence against women and girls in the United States and around the world through education, programs and policy. In past years, OWH has focused on how violence affects women with disabilities, men as partners in prevention of violence, and the role of colleges and universities in preventing sexual assault and violence against women. This Funding Opportunity Announcement (FOA) solicits applications for projects focused on policies to address sexual assault on college campuses. These awards will be used to enhance and implement sexual assault prevention policies through provision of national outreach and technical assistance, development of institutional partnerships, and creation of campus coalitions. OWH encourages national or regional membership-driven organizations who represent interest groups or populations that serve and support post-secondary schools, colleges and universities to apply. This funding opportunity was announced on March 5, 2015. The application deadline is May 18, 2015. For more information, please visit OASH's Full Funding Opportunity Announcement.

 

SAMHSA: Supplement for Addiction Technology Transfer Center (ATTC) for a Center of Excellence on Behavioral Health for Pregnant and Postpartum Women (PPW) and their Families

Funding Opportunity Number: TI-15-008

This Funding Opportunity Announcement (FOA) seeks to enable one grantee from the fiscal year (FY) 2012 Addiction Technology Transfer Centers (ATTC) cohort to expand/enhance grant activities required under the 2012 Request for Applications (RFA) by developing a Pregnant and Postpartum Women (PPW) Center of Excellence (CoE). This CoE will develop and strengthen the behavioral healthcare workforce that provides addiction treatment and recovery support services to PPW, their children, and their families. SAMHSA currently funds 10 regional ATTCs that provide crucial support for addressing behavioral health issues at the regional and local levels. In addition, four ATTCs receive funding to address a national focus area and one ATTC serves as the national coordinating office. These 15 ATTCs provide comprehensive support with respect to developing and enhancing the workforce. In order to develop and disseminate a PPW curriculum, a current ATTC grantee will develop a Center of Excellence (CoE) to develop and strengthen the behavioral healthcare workforce that provides addiction treatment and recovery support services to PPW, their children, and their families. The CoE will develop a training curriculum/toolkit for implementing the current PPW family-centered approach. This funding opportunity was announced on March 6, 2015. The application deadline is May 11, 2015. For more information, please visit SAMHSA's Full Funding Opportunity Announcement.

 

USAMRAA: Breast Cancer Distinguished Investigator Award

Funding Opportunity Number: W81XWH-15-BCRP-DIA

The BCRP Distinguished Investigator Award enables established visionary leaders from any field to pursue innovative ideas that could accelerate progress toward ending breast cancer. These individuals should be exceptionally talented researchers who have shown that they are leaders in their field(s) through extraordinary creativity, vision, and productivity. The Principal Investigator (PI) is expected to have a renowned reputation as a researcher who has made groundbreaking contributions to advancing his/her field. The PI should have demonstrated success at forming and leading effective partnerships and collaborations. Through his/her distinguished record of research and leadership, the PI should demonstrate the potential to make unique and significant advances in breast cancer. The central feature of the Distinguished Investigator Award is that the PI must propose research that is a fundamental shift from his/her track record of research and addresses one or more BCRP overarching challenge(s). Proposals that are a continuation or incremental change from the PI’s published line of research do not meet the intent of this award. High-risk/high-reward proposals with limited preliminary data are welcomed, but not required. Experience in breast cancer research is not required; however, the application must focus on breast cancer. Individuals from other disciplines who will apply novel concepts to breast cancer are encouraged to submit. The PI is expected to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. If the PI does not have experience in breast cancer, inclusion of at least one collaborator with breast cancer expertise on the research team is required. The PI’s research team must also include two or more breast cancer consumer advocates who must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at risk for, breast cancer. This funding opportunity was announced on March 3, 2015. The application deadline is July 28, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Breast Cancer Era of Hope Scholar Award

Funding Opportunity Number: W81XWH-15-BCRP-EOHS

The Era of Hope Scholar Award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the “best and brightest” in their field(s) through extraordinary creativity, vision, leadership, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and should exhibit strong potential for future leadership in the breast cancer research community. Since the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central focus of the award is the applicant’s demonstrated ability to go beyond conventional thinking in his or her field and the innovative contribution that the Principal Investigator (PI) can make toward ending breast cancer. The PI should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention. This funding opportunity was announced on March 3, 2015. The application deadline is April 22, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

 

 

 

USAMRAA: Breast Cancer Innovator Award

Funding Opportunity Number: W81XWH-15-BCRP-INNOV

The Innovator Award supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could accelerate progress to ending breast cancer. Since the intent of the Innovator Award mechanism is to recognize these remarkably creative and innovative, visionary individuals rather than projects, the central focus of the award is the innovative contribution that the Principal Investigator (PI) can make toward ending breast cancer. The PI should have a past record of challenging the status quo, shifting paradigms by changing a field of research or approach to patient care, exhibiting high levels of creativity, and demonstrating promise for continued innovation in future work. These rare individuals will be able to articulate a vision for ending breast cancer that challenges current dogma and demonstrates an ability to look beyond tradition and convention. The PI is also expected to be established in his/her field and have demonstrated success at forming and leading effective partnerships and collaborations. To further the development of innovative individuals and spark the generation of novel ideas, applications are required to incorporate the mentoring of promising junior investigators. Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must maintain a 50% dedication of his/her full-time professional effort during the award period to breast cancer research. The PI is expected to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PI’s research team must also include two or more breast cancer consumer advocates who must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be focused on providing objective input on the research and its potential impact for individuals with, or at risk for, breast cancer. This funding opportunity was announced on March 3, 2015. The application deadline is July 28, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

 

USAMRAA: DoD Breast Cancer Breakthrough Award Levels 1 and 2

Funding Opportunity Number: W81XWH-15-BCRP-BREAKTHROUGH-FL12

The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome. Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. Two additional funding levels, Funding Levels 3 and 4, are available under a different Program Announcement (FOA Number W81XWH-15-BCRP-BREAKTHROUGH_FL34). It is the responsibility of the Principal Investigator (PI) to select the funding level that is most appropriate for the research proposed. The funding level should be selected based on the scope of the research project, rather than the amount of the budget. The Breakthrough Award encourages applications that include meaningful and productive collaborations between investigators. The Partnering PI Option is structured to accommodate two PIs, called the Initiating PI and the Partnering PI, each of whom will receive a separate award. The Initiating and Partnering PIs have different submission requirements; however, both PIs should contribute significantly to the development of the proposed research project including the Project Narrative, Statement of Work (SOW), and other required components. The PIs may have expertise in similar or disparate scientific disciplines, but each PI is expected to bring distinct contributions to the application. New collaborations are encouraged, but not required. It is the responsibility of the PIs to describe how their combined expertise will better address the research question and explain why the work should be done together rather than through separate efforts. To meet the intent of the Partnering PI Option, applicants are discouraged from submitting as a Partnering PI on multiple applications unless they are clearly addressing distinct research questions. This funding opportunity was announced on March 3, 2015. The application deadline is April 22, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Breast Cancer Breakthrough Award Levels 3 and 4

Funding Opportunity Number: W81XWH-15-BCRP-BREAKTHROUGH-FL34

The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome. Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. Two additional funding levels, Funding Levels 3 and 4, are available under a different Program Announcement (W81XWH-15-BCRP-BREAKTHROUGH_FL12). It is the responsibility of the Principal Investigator (PI) to select the funding level that is most appropriate for the research proposed. The funding level should be selected based on the scope of the research project, rather than the amount of the budget. The Breakthrough Award encourages applications that include meaningful and productive collaborations between investigators. The Partnering PI Option is structured to accommodate two PIs, called the Initiating PI and the Partnering PI, each of whom will receive a separate award. The Initiating and Partnering PIs have different submission requirements; however, both PIs should contribute significantly to the development of the proposed research project including the Project Narrative, Statement of Work (SOW), and other required components. The PIs may have expertise in similar or disparate scientific disciplines, but each PI is expected to bring distinct contributions to the application. New collaborations are encouraged, but not required. It is the responsibility of the PIs to describe how their combined expertise will better address the research question and explain why the work should be done together rather than through separate efforts. To meet the intent of the Partnering PI Option, applicants are discouraged from submitting as a Partnering PI on multiple applications unless they are clearly addressing distinct research questions. This funding opportunity was announced on March 3, 2015. The application deadline is July 28, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

USAMRAA: Bone Marrow Failure Research Program Idea Development Award

Funding Opportunity Number: W81XWH-15-BMFRP-IDA

The Bone Marrow Failure Research Program (BMFRP) Idea Development Award is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP vision of understanding and curing BMF diseases. This award is designed to support new ideas. Proposed research studies should have a high probability of revealing new avenues of investigation. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale and a developed and well-articulated research approach. Personnel on the proposed team should have a strong background in BMF research. This funding opportunity is open to established and early career investigators. To encourage the application of early career investigators, the BMFRP has included an opportunity for one or more scientifically meritorious applications from applicants fitting the outlined description of an early career investigator. Early career investigators are defined as being within 10 years of completing a terminal degree (doctorate or any medical degree), excluding time spent in medical residency, or during family medical leave. This should be clearly articulated by the applicant in the biographical sketch. This funding opportunity was announced on March 3, 2015. The application deadline is July 21, 2015. For more information, please visit the Army's Full Funding Opportunity Announcement.

 

NIH Funding Opportunity Announcements:

 

NIH: Investigations on Primary Immunodeficiency Diseases

Funding Opportunity Number: PAR-15-130

The primary purpose of this Funding Opportunity Announcement (FOA) is to support innovative investigations of primary immunodeficiency diseases. A secondary purpose is to expand the field by attracting additional investigators to primary immunodeficiency diseases research. Studies using human specimens ex vivo and studies with animal models are encouraged. This FOA will support novel strategies to detect primary immunodeficiency diseases, to identify their molecular basis, and to develop innovative therapies. Primary immunodeficiency diseases result from inherited defects in the immune system caused by genetic variants, in contrast to secondary immunodeficiency diseases that develop when the immune system is compromised by extrinsic factors such as viruses or chemotherapy. More than 250 primary immunodeficiency diseases and 150 genes causing these diseases have been identified. Although individual primary immunodeficiency diseases are rare, as a group they may affect 1-2% of the population. The severity of these diseases ranges from mild to life threatening, as is the case of severe combined immunodeficiency disease (SCID). In addition to benefitting millions of patients affected with primary immunodeficiency diseases, research in this field can provide crucial information on the development and function of the human immune system. This funding opportunity was announced on March 4, 2015. The initial application deadline is June 5, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium

Funding Opportunity Number: RFA-AR-15-014

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Validation of Pediatric Patient Reported Outcomes in Chronic Diseases (PEPR) Consortium. The National Institutes of Health intends to capitalize on recent advances in the science of Patient Reported Outcomes (PROs) to measure the patient experience in clinical care and research in children with a variety of chronic diseases and conditions (e.g., asthma, juvenile arthritis, cystic fibrosis, diabetes, obesity, chronic kidney disease, inflammatory bowel disease, sickle cell disease, malnutrition, developmental disabilities including attention deficit/hyperactivity disorder and autism spectrum disorder, cerebral palsy and mental illnesses) using the Patient-Reported Outcomes Measurement Information System (PROMIS) tools and approaches coupled with detailed clinical phenotyping and/or biospecimen collection in well-characterized human cohorts. PROMIS is a system of highly reliable, precise measures of patient-reported health status for physical, mental, and social wellbeing. PROMIS tools measure what patients are able to do and how they feel by asking questions. PROMIS measures can be used as primary or secondary endpoints in clinical studies of the effectiveness of treatment. This funding opportunity was announced on March 6, 2015. The application deadline is June 2, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

NIH: Functional Wellness in HIV: Maximizing the Treatment Cascade

Funding Opportunity Numbers: PA-15-133 and PA-15-134

The National Institute of Nursing Research (NINR) seeks to promote the development of HIV interventions which target opportunities to improve the delivery of healthcare across the continuum of care for persons infected with HIV. The goal of this Funding Opportunity Announcement (FOA) is develop interventions aimed at increasing functional wellness in persons infected with HIV by entry and maintenance in the HIV treatment cascade (the cascade). The cascade provides the steps required to determine HIV status and retain individuals in HIV care. The benefits of increasing adherence to the cascade could be ‘functional wellness,’ a new construct in this area.  Functional wellness is defined for this initiative as a person-centered balance between internal (individual responses to stress, illness, medication; personal or cultural behaviors) and external factors (learning new or adaptive strategies for current roles, managing one’s physical, emotional and environmental health) affecting health, and developing action plans toward healthy living and wellness.  Maximizing health and maintaining functional wellness in HIV/AIDS requires participation in each level of the cascade (test, diagnose, link, treat and retain in care). The ultimate benefit of adherence to the cascade is HIV viral load reduction leading to a functional cure (undetectable viremia without antiretroviral therapy, disease progression or the loss of CD4, and the inability to transmit the virus). These funding opportunities were announced on March 5, 2015. The application deadline for PA-15-133 is June 5, 2015. The application deadline for PA-15-134 is June 16, 2015. For more information, please visit NIH's Full Funding Opportunity Announcements for PA-15-133 and PA-15-134.

 

NIH: Biological and Physiological Effects of E-cigarette Aerosol Mixtures

Funding Opportunity Numbers: RFA-DE-16-004 and RFA-DE-16-005

The purpose of this Funding Opportunity Announcement (FOA) is to support research aimed at understanding the biological and physiological effects of aerosol mixtures produced by electronic cigarettes (ECs) on cells, tissues and organs of the oral cavity including oral and periodontal epithelia, gingiva, salivary glands, and tooth. ECs are battery operated devices, which consist of a metal heating element that vaporizes a solution containing a mixture of chemicals including nicotine and other additives such as propylene glycol, glycerine, and flavoring agents. There is limited scientific evidence to support the safety of ECs.  Initial studies indicate that a variety of chemicals and metal particles are produced by these devices during the vaporization of nicotine and the other EC components.  Some of the chemicals identified in the aerosols of ECs include propylene glycol, glycerine, formaldehyde, acetaldehyde, acrolein, toluene, nitrosamines, nickel, cadmium, aluminum, silicon and lead. This FOA will also support research on elucidation of the effects of ECs on oral microbiome. Research supported by this FOA will provide essential and necessary information on the biological effects of ECs that would in turn lead to evidence based foundational information for health policy decisions. These funding opportunities were announced on March 5, 2015. A letter of intent for each opportunity is due by June 28, 2015. The application deadline for both opportunities is July 28, 2015. For more information, please visit NIH's Full Funding Opportunity Announcements for RFA-DE-16-004 and RFA-DE-16-005.

 

NIH: National Biocontainment Laboratories (NBLs) Operations Support

Funding Opportunity Number: RFA-AI-15-009

The goal of this Funding Opportunity Announcement (FOA) is to continue to provide operations support for Biosafety Level 4 (BSL4) facilities at the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs will serve as a national resource for efforts in conducting clinical and laboratory (in vitro and in vivo) research and testing on hazardous biological agents in support of the Biodefense Research Agenda and other infectious diseases. This funding opportunity was announced on March 6, 2015. The application deadline is April 29, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.


Association Management Software Powered by YourMembership  ::  Legal